Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

cardiovascular · Mechanism Report

Is the GUCY1A3 rs7692387 GG genotype linked to reduced nitric oxide signaling and higher coronary artery disease risk?

The GUCY1A3 rs7692387 GG genotype is associated with blunted nitric-oxide signaling and increased coronary artery disease susceptibility.

PlausibleSeptember 14, 20264 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The GUCY1A3 rs7692387 GG genotype is associated with reduced soluble guanylate cyclase signaling downstream of nitric oxide and increased coronary artery disease susceptibility.

laying out figure…
2 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says the GG genotype is linked to reduced soluble guanylate cyclase activity downstream of nitric oxide, with lower cGMP signaling as part of the mechanism. It also frames the variant as a modest inherited susceptibility factor for coronary artery disease, with functional effects that can weaken platelet inhibition and vascular smooth-muscle regulation.

Verified conclusion

The GUCY1A3 rs7692387 variant links a modest inherited coronary-artery-disease (CAD) risk signal to a biologically coherent defect in nitric-oxide (NO) signaling. For the stated GG genotype, the overall evidence supports both attenuated NO–soluble guanylate cyclase (sGC)–cGMP activity and increased CAD susceptibility, with moderate confidence.

Clinical association

  • Predominantly European-ancestry genome-wide association data identify the G allele as CAD risk-increasing, with a combined per-allele odds ratio of 1.13 (P=2.65×10⁻¹¹) after replication evidence of OR 1.06.
  • European cohort findings report greater cardiovascular risk in GG homozygotes than in A-allele carriers. This is a modest susceptibility effect, not a deterministic cause of CAD or a standalone individual risk-prediction test.
  • Association is ancestry-qualified: a Southeast Asian multi-ethnic analysis was weaker and nonsignificant (OR 0.93, 95% CI 0.85–1.01).

Mechanistic evidence

  • rs7692387 is an intronic regulatory locus in a DNase-sensitive region. Altered ZEB1 binding has been reported to reduce GUCY1A3 transcription, lowering expression of the sGC α1 subunit.
  • Lower sGC α1 abundance is accompanied by reduced NO-stimulated sGC activity and cGMP generation—the signaling pathway through which NO promotes vascular relaxation and restrains platelet activation.
  • In platelets from risk-homozygous carriers, NO-donor exposure produced lower cGMP, weaker VASP phosphorylation, and less inhibition of aggregation. In vascular smooth-muscle cells, sGC-mediated suppression of cell migration was markedly reduced or absent. These findings provide plausible prothrombotic and pro-atherosclerotic links.

Bottom line

  • The GG genotype is supported as a marker of blunted NO–sGC–cGMP signaling and modestly increased CAD susceptibility, especially in European-ancestry populations; its clinical meaning should be interpreted alongside established cardiovascular risk factors rather than in isolation.

References

  1. Functional Characterization of the GUCY1A3 Coronary ... — ahajournals.org ↗
  2. Functional Characterization of the GUCY1A3 Coronary ... — pubmed.ncbi.nlm.nih.gov ↗
  3. Edinburgh Research Explorer — pure.ed.ac.uk ↗
  4. Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesAre F2-isoprostanes biomarkers of lipid peroxidation and does oxidized LDL contribute to atherosclerosis?→Plausible10 sourcesDo hs-CRP, Lp-PLA2, and myeloperoxidase reflect different cardiovascular risk signals?→